General Information of Drug Transporter (DT)
DT ID DTD0189 Transporter Info
Gene Name SLC25A28
Transporter Name Mitochondrial iron transporter 2
Gene ID
81894
UniProt ID
Q96A46
Post-Translational Modification of This DT
Overview of SLC25A28 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Methylation X-Phosphorylation X: Amino Acid

Methylation

  Arginine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A28 [1]

Role of PTM

Potential impacts

Modified Residue

Arginine

Modified Location

6

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC25A28 Arginine 6 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A28 [1]

Role of PTM

Potential impacts

Modified Residue

Arginine

Modified Location

39

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC25A28 Arginine 39 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A28 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

22

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A28 Serine 22 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A28 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

26

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A28 Serine 26 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A28 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

334

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A28 Tyrosine 334 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A28 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

346

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A28 Tyrosine 346 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A28 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

351

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A28 Tyrosine 351 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: MFRN2_HUMAN)
2 Combination of chemical genetics and phosphoproteomics for kinase signaling analysis enables confident identification of cellular downstream targets. Mol Cell Proteomics. 2012 Apr;11(4):O111.012351.
3 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
4 Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.